Table 4.
Density | Normal | High | P-value | |||||
---|---|---|---|---|---|---|---|---|
Methionine | 100% | 130% | 100% | 130% | SEM | Density | MET | Interaction |
Grower | ||||||||
Breast | ||||||||
TC, mg/g protein | 2.80 | 2.83 | 2.88 | 2.91 | 0.05 | 0.63 | 0.84 | 1.00 |
TG, mg/g protein | 16.3 | 15.2 | 11.7 | 11.2 | 2.58 | 0.07 | 0.64 | 1.00 |
NEFA, μmol/g protein | 4.91 | 5.81 | 4.85 | 4.63 | 0.52 | 0.09 | 0.37 | 0.13 |
Thigh | ||||||||
TC, mg/g protein | 4.23 | 4.05 | 3.97 | 3.80 | 0.06 | 0.29 | 0.48 | 0.98 |
TG, mg/g protein | 27.4 | 24.6 | 23.6 | 24.5 | 1.53 | 0.62 | 0.82 | 0.65 |
NEFA, μmol/g protein | 10.1 | 10.5 | 8.69 | 9.02 | 0.79 | 0.28 | 0.78 | 0.98 |
Liver | ||||||||
TC, mg/g protein | 12.8 | 13.2 | 12.3 | 14.3 | 0.74 | 0.72 | 0.19 | 0.40 |
TG, mg/g protein | 25.9 | 30.1 | 24.5 | 28.6 | 2.28 | 0.50 | 0.05 | 1.00 |
NEFA, μmol/g protein | 43.5 | 44.8 | 41.7 | 42.7 | 1.30 | 0.60 | 0.75 | 0.96 |
Finisher | ||||||||
Breast | ||||||||
TC, mg/g protein | 4.83 | 4.39 | 4.99 | 4.81 | 0.25 | 0.21 | 0.17 | 0.55 |
TG, mg/g protein | 25.0 | 18.1 | 17.9 | 24.9 | 3.85 | 0.92 | 0.90 | 0.09 |
NEFA, μmol/g protein | 4.78ab | 3.68b | 4.75ab | 5.67a | 0.71 | 0.07 | 0.85 | 0.05 |
Thigh | ||||||||
TC, mg/g protein | 3.75 | 3.82 | 3.81 | 3.69 | 0.06 | 0.82 | 0.88 | 0.54 |
TG, mg/g protein | 19.9 | 26.6 | 24.9 | 29.4 | 3.52 | 0.34 | 0.18 | 0.80 |
NEFA, μmol/g protein | 3.92 | 4.29 | 4.93 | 5.29 | 0.57 | 0.08 | 0.52 | 0.99 |
Liver | ||||||||
TC, mg/g protein | 12.8 | 13.5 | 14.5 | 13.6 | 0.68 | 0.24 | 0.95 | 0.29 |
TG, mg/g protein | 57.2 | 70.7 | 77.2 | 72.0 | 8.24 | 0.19 | 0.63 | 0.25 |
NEFA, μmol/g protein | 32.6 | 38.3 | 37.8 | 43.7 | 4.28 | 0.09 | 0.07 | 0.98 |
1Data are expressed as means (n = 10). The main effects (the stocking density and concentration of supplemental dl-methionine) were analyzed by two-way ANOVA and Duncan’s multiple range test was used to compare the treatment means. Means in the same row without a common letter differ significantly (P < 0.05).